Keyphrases
Parkinson's Disease
100%
Gain-of-function mutation
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
LRRK1
50%
Odds Ratio
14%
Loss Function
14%
Therapeutic Strategies
7%
Molecular Mechanism
7%
Protein Level
7%
Further Analysis
7%
Double Knockout
7%
Cell Death
7%
Phosphorylation
7%
Genetic Causes
7%
Mouse Model
7%
Gain-of-function
7%
Pathogenic Variants
7%
Neurodegeneration
7%
Human Population
7%
Underlying Disease
7%
Association Test
7%
Disease-modifying Therapy
7%
Haploinsufficiency
7%
Next-generation Sequencing Data
7%
Lymphoblastoid Cell Lines
7%
Kinase Inhibition
7%
Function Model
7%
Potential Diseases
7%
Neurologically Normal
7%
Allele-specific Targeting
7%
LRRK2 Inhibitors
7%
Biochemistry, Genetics and Molecular Biology
LRRK2
100%
LRRK1
42%
Allele
14%
Wild Type
7%
Genetics
7%
Mouse Model
7%
Cell Death
7%
Kinase
7%
Phosphotransferase
7%
Next Generation Sequencing
7%
Haploinsufficiency
7%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Diseases
40%
Phosphotransferase
10%
Mouse Model
10%
Nerve Degeneration
10%
Leucine Rich Repeat Kinase 2
10%
Neuroscience
Parkinson's Disease
100%
Cell Line
10%
Kinase
10%
Cell Death
10%
Neurodegeneration
10%
Haploinsufficiency
10%
Leucine Rich Repeat Kinase 2
10%